Hasita Horlad Selected Research

Hasita Horlad Research Topics

Disease

21	Neoplasms (Cancer) 06/2022 - 01/2008
6	Lymphoma (Lymphomas) 06/2022 - 01/2013
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 07/2017 - 07/2013
3	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2011
3	Hepatocellular Carcinoma (Hepatoma) 10/2010 - 01/2008
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 06/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017 - 07/2017
2	Atherosclerosis 07/2013 - 03/2012
2	Hyperlipidemias (Hyperlipidemia) 07/2013 - 03/2012
1	COVID-19 01/2023
1	Arthritis (Polyarthritis) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Disease Progression 03/2018
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Ductal Carcinoma 08/2017
1	Ovarian Neoplasms (Ovarian Cancer) 12/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2016
1	Stomach Neoplasms (Stomach Cancer) 07/2015
1	Kidney Neoplasms (Kidney Cancer) 06/2015
1	Fibrosis (Cirrhosis) 03/2014
1	Persistent Infection 01/2014
1	T-Cell Leukemia (Leukemia, T Cell) 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 06/2013
1	Glioma (Gliomas) 12/2012
1	Cholangiocarcinoma 11/2012
1	Hemorrhage 05/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 07/2017 - 01/2011
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017 - 01/2011
3	onionin AIBA 06/2022 - 11/2016
3	CytokinesIBA 01/2020 - 01/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2013
3	Messenger RNA (mRNA)IBA 08/2017 - 06/2013
3	MucinsIBA 07/2017 - 09/2015
3	Immunoglobulins (Immunoglobulin)IBA 07/2017 - 09/2015
2	CholesterolIBA 06/2022 - 03/2012
2	ParaffinIBA 08/2017 - 11/2016
2	Conditioned Culture MediaIBA 08/2017 - 01/2011
2	Immune Checkpoint ProteinsIBA 07/2017 - 11/2016
2	LigandsIBA 07/2017 - 11/2016
2	Apolipoproteins E (ApoE)IBA 07/2013 - 03/2012
2	Bromodeoxyuridine (BrdU)IBA 07/2013 - 12/2012
2	Cholesterol Esters (Cholesteryl Esters)IBA 07/2013 - 03/2012
1	VaccinesIBA 01/2023
1	PD 128042IBA 06/2022
1	LipidsIBA 06/2022
1	Interleukin-10 (Interleukin 10)IBA 06/2022
1	Sulfur Compounds (Compounds, Sulfur)IBA 06/2022
1	epimedokoreanin BIBA 01/2020
1	epimedii flavoneIBA 01/2020
1	CollagenIBA 01/2020
1	FlavonoidsIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	CD163 antigenIBA 03/2018
1	Cell Adhesion Molecule-1IBA 07/2017
1	Cell Adhesion MoleculesIBA 07/2017
1	WP1066IBA 07/2017
1	TL 1IBA 07/2017
1	Interleukin-27 (Interleukin 27)IBA 11/2016
1	Cisplatin (Platino)FDA LinkGeneric 11/2016
1	SulfurIBA 11/2016
1	HLA-DR Antigens (HLA-DR)IBA 03/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016
1	MicroRNAs (MicroRNA)IBA 07/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2015
1	MAP Kinase Kinase Kinase 5IBA 03/2014
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2014
1	AlkaloidsIBA 07/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2013
1	manzamine AIBA 07/2013
1	corosolic acidIBA 06/2013
1	Antineoplastic Agents (Antineoplastics)IBA 06/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013
1	Complement C5a (Complement 5a)IBA 01/2013
1	Small Interfering RNA (siRNA)IBA 12/2012
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 12/2012
1	Macrophage Colony-Stimulating FactorIBA 12/2012
1	A-factor (Streptomyces)IBA 11/2012
1	TomatineIBA 03/2012
1	esculeoside AIBA 03/2012
1	isoesculeogenin AIBA 03/2012
1	TransferasesIBA 03/2012
1	tomatidineIBA 03/2012
1	Acyl Coenzyme A (Acyl CoA)IBA 03/2012
1	Mitogen-Activated Protein KinasesIBA 01/2011
1	Tumor Biomarkers (Tumor Markers)IBA 10/2010

Therapy/Procedure

7	Therapeutics 06/2022 - 01/2008
2	Immunotherapy 07/2017 - 11/2016
2	Drug Therapy (Chemotherapy) 08/2016 - 01/2011
1	Oral Administration 01/2020
1	Ligation 03/2014
1	Length of Stay 05/2012
1	Hepatectomy 10/2010
1	Radiofrequency Ablation 05/2009